Bovine Leukemia Virus: Past, Present and Future

  • A. Burny
  • C. Bruck
  • D. Couez
  • J. Deschamps
  • J. Ghysdael
  • D. Gregoire
  • R. Kettmann
  • M. Mammerickx
  • D. Portetelle
  • N. Rice
  • R. Stephens
  • R. Gilden
Part of the Developments in Oncology book series (DION, volume 28)


Enzootic bovine leukemia has been perceived as an infectious cancer since about 50 years. Appearance of tumor cases has been linked to introduction, in a naïve herd, of animals coming from a “tumor case” herd and experimental transmission experiments easily showed that an agent was indeed most probably involved. The exact nature of the agent remained elusive until 1969, when Miller and coworkers (1) observed virus particles in short term cultures of lymphocytes from animals in persistent lymphocytosis, a condition frequently associated with increased risk of leukemia. Since 1969, the virus itself, its host-range and mode of propagation, its interactions with the host and ways of leukemogenesis, ... have been the subject of intense investigation. The nucleotide sequence of several BLV proviruses is now known, thus allowing deep insight to be gained into virus integration and expression and hypotheses to be put forward about putative modes of action. Times are now ripe and the tools are available to undertake a detailed analysis of the chain of events that starts at infection and ends with full blow of the tumor phase. It had been observed, already in 1972 (2), that BLV behaved as a separate entity from the then known retroviruses.


Long Terminal Repeat Bovine Leukemia Virus Nucleic Acid Binding Protein Amino Acid Sequence Data Feline Leukemia Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Miller J.M., Miller L.D., Olson C. and Gillette K.G.: Virus-like particles in phytohaemagglutinin-stimulated lymphocyte cultures with reference to bovine lymphosarcoma. J. Nat. Cancer Inst. (43): 1297–1305, 1979.Google Scholar
  2. 2.
    Ferrer J.F.: Antigenic comparison of bovine type-C virus with murine and feline leukemia viruses. Cancer Res. (32): 1871–1877, 1972.PubMedGoogle Scholar
  3. 3.
    Kettmann R., Couez D. and Burny A.: Restriction endonuclease mapping of linear unintegrated proviral DNA of bovine leukemia virus. J. Virol. (38): 27–33, 1981.PubMedGoogle Scholar
  4. 4.
    Deschamps J., Kettmann R. and Burny A.: Experiments with cloned complete tumor-derived bovine leukemia virus information prove that the virus is totally exogenous to its target animal species. J. Virol. (40): 605–609, 1981.PubMedGoogle Scholar
  5. 5.
    Kashmiri S.V.S., Mehdi R. and Ferrer J.F.: Molecular cloning of covalently closed circular DNA of bovine leukemia virus. J. Virol. (49): 583–587, 1983.Google Scholar
  6. 6.
    Kashmiri S.V.S., Mehdi R. and Ferrer J.F.: Molecular cloning of covalently closed circular DNA of bovine leukemia virus. J. Virol. (49): 583–587, 1984.PubMedGoogle Scholar
  7. 7.
    Sagata N., Ogawa Y., Kawamura J., Onuma M., Izawa H. and Ikawa Y.: Molecular cloning of bovine leukemia virus DNA integrated into the bovine tumor cell genome. Gene (26): 1–10, 1983.PubMedCrossRefGoogle Scholar
  8. 8.
    Copeland T.D., Morgan M.A. and Orozzlan S.: Complete amino acid sequence of the nucleic acid binding protein of bovine leukemia virus. FEBS Letters (156): 37 - 40, 1983a.PubMedCrossRefGoogle Scholar
  9. 9.
    Copeland T., Oroszlan S., Kalyanaraman V.S., Sarngadharan M.G. and Gallo R.C.: Complete amino acid sequence of human T-cell leukemia virus structural protein p15. FEBS Letters (162): 390–395, 1983b.PubMedCrossRefGoogle Scholar
  10. 10.
    Burny A., Bruck C., Cleuter Y., Couez D., Dekegel D., Deschamps J., Ghysdael J., Gilden R.V., Kettmann R., Marbaix G., Mammerickx M. and Portetelle D.: Leukemogenesis by bovine leukemia virus. In: Mechanisms of viral leukemogenesis vol. 1, eds J. Goldmann and O. Jarrett, Edinburgh, Churchill Livingstone. 1976,pp. 229–260.Google Scholar
  11. 11.
    Couez D., Deschamps J., Kettmann R., Stephens R., Gilden R. and Burny A.: Nucleotide sequence analysis of the long terminal repeat of integrated bovine leukemia provirus DNA and of adjacent viral and host sequences. J. Virol. (49): 615–620, 1984.PubMedGoogle Scholar
  12. 12.
    Czernilofsky A.P., De Lorbe W., Swanstrom R., Varmus H.E., Bishop J.M., Fischer E. and Goodman H.M.: The nucleotide sequence of an untranslated but conserved domain at the 3’ end of the avian sarcoma virus genome. Nucl. Ac. Res. (8): 2967 2984, 1980.Google Scholar
  13. 13.
    Robinson H.L., Blais B.M., Tsichlis P.L. and Coffin J.M.: At least two regions of the viral genome determine the oncogenic potential of avian leukosis viruses. Proc. Nat. Acad. Sci. U.S.A. (79): 1225–1229, 1982.CrossRefGoogle Scholar
  14. 14.
    Tsichlis P.N. and Coffin J.M.: Recombinants between endogenous and exogenous avian tumor viruses: role of the C region and other portions of the genome in the control of replication and transformation. J. Virol. (33): 238–249, 1980.PubMedGoogle Scholar
  15. 15.
    Lenz J., Celander D., Crowther R.L., Patarca R., Perkins D.W. and Haseltine W.A.: Determination of the leukemogenicity of a murine retrovirus by sequences within the long terminal repeat. Nature (308): 467–470, 1984.PubMedCrossRefGoogle Scholar
  16. 16.
    Chen I.S.Y., McLaughlin J. and Golde D.W.: Long terminal repeats of human T-cell leukemia virus II genome determine target cell specificity. Nature (309): 276–279, 1984.PubMedCrossRefGoogle Scholar
  17. 17.
    Rice N.R., Stephens R.M., Couez D., Deschamps J., Kettmann R., Burny A. and Gilden R.V.: The nucleotide sequence of the env gene and post-env region of bovine leukemia virus. Virology, in press, 1984.Google Scholar
  18. 18.
    Schultz A.M., Copeland T.D. and Oroszlan S.: The envelope proteins of bovine leukemia virus: purification and sequence analysis. Virology 135, in press, 1984.Google Scholar
  19. 19.
    Ghysdael J., Kettmann R. and Burny A.: Translation of bovine leukemia virus virion RNAs in heterologous protein-synthesizing systems. J. Virol. (29): 1087–1098, 1979.PubMedGoogle Scholar
  20. 20.
    Kettmann R., Deschamps J., Couez D., Claustriaux J.J., Palm R. and Burny A.: Chromosome integration domain for bovine leukemia provirus in tumors. J. Virol. (47): 146–150, 1983.PubMedGoogle Scholar
  21. 21.
    Grégoire D., Couez D., Deschamps J., Heuertz S., Hors Cayla M.C., Szpirer J., Szpirer C., Burny A., Huez G. and Kettmann R.: Different bovine leukemia virus-induced tumors harbor the provirus in different chromosomes. J. Virol. (50): 275–279, 1984.PubMedGoogle Scholar
  22. 22.
    Burny A., Bruck C., Chantrenne H., Cleuter Y., Dekegel D., Ghysdael J., Kettmann R., Leclercq M., Leunen J., Mammerickx M. and Portetelle D.: Bovine leukemia virus: molecular biology and epidemiology. In: Viral Oncology, ed G. Klein. New York, Raven Press, 1980, pp. 231–289.Google Scholar
  23. 23.
    Uckert W., Wunderlich V., Ghysdael J., Portetelle D. and Burny A.: Bovine leukemia virus BLV- A structural model based on chemical crosslinking studies. Virology (133): 386–392, 1984.PubMedCrossRefGoogle Scholar
  24. 24.
    Morgan M.A., Copeland T.D. and Oroszlan S.: Structural and antigenic analysis of the nucleic acid binding proteins of bovine and feline leukemia viruses. J. Virol. (46): 177–186, 1983.PubMedGoogle Scholar
  25. 25.
    Schultz A.M. and Oroszlan S.: Myristylation of gag-onc fusion proteins in mammalian transforming retroviruses. Virology (133): 431–437, 1984.PubMedCrossRefGoogle Scholar
  26. 26.
    Prachar J. and Hlubinova K. 1980. Glycoprotein and protein composition of BLV. Neoplasma (27): 669–674, 1980.PubMedGoogle Scholar
  27. 27.
    Uckert W., Westermann P. and Wunderlich V.: Nearest neighbor relationship of major structural proteins within bovine leukemia virus particles. Virology (121): 240–250, 1982.PubMedCrossRefGoogle Scholar
  28. 28.
    Long C.W., Henderson L.E. and Oroszlan S.: Isolation and characterization of low molecular-weight DNA-binding proteins from retroviruses. Virology (104): 491–496, 1980.PubMedCrossRefGoogle Scholar
  29. 29.
    Gilden R.V., Long C.W., Hanson M., Toni R., Charman H., Oroszlan S., Miller J.M. and Van der Maaten M.J.: Characterization of the major internal protein and RNA-dependent DNA polymerase of bovine leukemia virus. J. Gen. Virol. (29): 305–314, 1975.PubMedCrossRefGoogle Scholar
  30. 30.
    Oroszlan S., Copeland T.D., Henderson L.E., Stephenson J.R. and Gilden R.V.: Amino-terminal sequence of bovine leukemia virus major internal protein: Homology with mammalian type C virus p30s. Proc. Nat. Acad. Sci. U.S.A. (76): 2996–3000, 1979.CrossRefGoogle Scholar
  31. 31.
    Bruck C., Rensonnet N., Portetelle D., Cleuter Y., Mammerickx M., Burny A., Mamoun R., Guillemain B., Van der Maaten M.J. and Ghysdael J.: Biologically active epitopes of bovine leukemia virus glycoprotein gp51: their dependence on protein glycosylation and genetic variability. Virology. In press, 1984.Google Scholar
  32. 32.
    Mamoun R.Z., Astier T., Guillemain B. and Duplan J.F.: Bovine lymphosarcoma: expression of BLV-related proteins in cultured cells. J. Gen. Virol. (64): 1895–1905, 1983.PubMedCrossRefGoogle Scholar
  33. 33.
    Bruck C., Mathot S., Portetelle D., Franssen J.D., Herion P. and Burny A.: Monoclonal antibodies define eight independent antigenic sites on the bovine leukemia virus envelope glycoprotein gp51. Virology (122): 343–352, 1982a.Google Scholar
  34. 34.
    Bruck C., Portetelle D., Burny A. and Zavada J.: Topographical analysis by monoclonal antibodies of BLV-gp51 epitopes involved in viral functions. Virology (122): 353–362, 1982b.PubMedCrossRefGoogle Scholar
  35. 35.
    Bruck C., Portetelle D., Mammerickx M., Mathot S. and Burny A.: Epitopes of bovine leukemia virus glycoprotein gp51 recognized by sera of infected cattle and sheep. Leukaemia Res.8: in press, 1984.Google Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1985

Authors and Affiliations

  • A. Burny
    • 1
    • 2
  • C. Bruck
    • 1
  • D. Couez
    • 1
  • J. Deschamps
    • 1
  • J. Ghysdael
    • 1
  • D. Gregoire
    • 1
  • R. Kettmann
    • 1
    • 2
  • M. Mammerickx
    • 3
  • D. Portetelle
    • 1
    • 2
  • N. Rice
    • 4
  • R. Stephens
    • 4
  • R. Gilden
    • 5
  1. 1.Departement of Molecular BiologyUniversity of BrusselsBelgium
  2. 2.Faculty of AgronomyGemblouxBelgium
  3. 3.National Institute for Veterinary ResearchUccleBelgium
  4. 4.LBI-Frederick Cancer Research FacilityNational Cancer InstituteFrederickUSA
  5. 5.PRI-Frederick Cancer Research FacilityNational Cancer InstituteFrederickUSA

Personalised recommendations